These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16359723)

  • 1. Separation-induced ultrasonic vocalization in rat pups: further pharmacological characterization.
    Iijima M; Chaki S
    Pharmacol Biochem Behav; 2005 Dec; 82(4):652-7. PubMed ID: 16359723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power spectrum analysis of ultrasonic vocalization elicited by maternal separation in rat pups.
    Ise S; Ohta H
    Brain Res; 2009 Aug; 1283():58-64. PubMed ID: 19523931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression.
    Hodgson RA; Higgins GA; Guthrie DH; Lu SX; Pond AJ; Mullins DE; Guzzi MF; Parker EM; Varty GB
    Pharmacol Biochem Behav; 2007 Mar; 86(3):431-40. PubMed ID: 17291571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor modulates maternal separation-induced ultrasonic vocalization in rat pups via activation of CRF1 receptor.
    Ise S; Nagano N; Okuda S; Ohta H
    Brain Res; 2008 Oct; 1234():59-65. PubMed ID: 18703034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups.
    Kehne JH; Coverdale S; McCloskey TC; Hoffman DC; Cassella JV
    Neuropharmacology; 2000 Jun; 39(8):1357-67. PubMed ID: 10818252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior.
    Hodgson RA; Mullins D; Lu SX; Guzzi M; Zhang X; Bleickardt CJ; Scott JD; Miller MW; Stamford AW; Parker EM; Varty GB
    Eur J Pharmacol; 2014 May; 730():157-63. PubMed ID: 24602808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat.
    Overstreet DH; Griebel G
    Pharmacol Biochem Behav; 2005 Sep; 82(1):223-7. PubMed ID: 16181667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in mice.
    Urani A; Philbert J; Cohen C; Griebel G
    Pharmacol Biochem Behav; 2011 May; 98(3):425-31. PubMed ID: 21356230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in rats.
    Shimazaki T; Iijima M; Chaki S
    Eur J Pharmacol; 2006 Aug; 543(1-3):63-7. PubMed ID: 16843459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of vasopressin 3 receptors in chronic psychological stress-induced visceral hyperalgesia in rats.
    Bradesi S; Martinez V; Lao L; Larsson H; Mayer EA
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G302-9. PubMed ID: 19033533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRF
    Verdouw PM; van Esterik JC; Peeters BW; Millan MJ; Groenink L
    Pharmacol Biochem Behav; 2017 Mar; 154():11-19. PubMed ID: 28089628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An arginine vasopressin V1b antagonist, SSR149415 elicits antidepressant-like effects in an olfactory bulbectomy model.
    Iijima M; Chaki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):622-7. PubMed ID: 17229509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists.
    Gilligan PJ; He L; Clarke T; Tivitmahaisoon P; Lelas S; Li YW; Heman K; Fitzgerald L; Miller K; Zhang G; Marshall A; Krause C; McElroy J; Ward K; Shen H; Wong H; Grossman S; Nemeth G; Zaczek R; Arneric SP; Hartig P; Robertson DW; Trainor G
    J Med Chem; 2009 May; 52(9):3073-83. PubMed ID: 19361210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Models of anxiety: ultrasonic vocalizations of isolated rat pups.
    Groenink L; Verdouw PM; van Oorschot R; Olivier B
    Curr Protoc Pharmacol; 2008 Dec; Chapter 5():Unit 5.18. PubMed ID: 22294223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression.
    Bespalov AY; van Gaalen MM; Sukhotina IA; Wicke K; Mezler M; Schoemaker H; Gross G
    Eur J Pharmacol; 2008 Sep; 592(1-3):96-102. PubMed ID: 18634781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted tetraazaacenaphthylenes as potent CRF1 receptor antagonists for the treatment of depression and anxiety.
    St-Denis Y; Di Fabio R; Bernasconi G; Castiglioni E; Contini S; Donati D; Fazzolari E; Gentile G; Ghirlanda D; Marchionni C; Messina F; Micheli F; Pavone F; Pasquarello A; Sabbatini FM; Zampori MG; Arban R; Vitulli G
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3713-6. PubMed ID: 15946843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CRF1 receptor antagonist, antalarmin, reverses isolation-induced up-regulation of dopamine D2 receptors in the amygdala and nucleus accumbens of fawn-hooded rats.
    Djouma E; Card K; Lodge DJ; Lawrence AJ
    Eur J Neurosci; 2006 Jun; 23(12):3319-27. PubMed ID: 16820021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists.
    Holsboer F; Ising M
    Eur J Pharmacol; 2008 Apr; 583(2-3):350-7. PubMed ID: 18272149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
    Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
    Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.